Results 201 to 210 of about 2,881,753 (249)

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang   +12 more
wiley   +1 more source

Design improvements and clinical evaluation of an adjustable clubfoot splint. [PDF]

open access: yesSci Rep
Beldar MK   +4 more
europepmc   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

An initial clinical evaluation of quantitative susceptibility mapping for quantitative characterization of intramyocardial hemorrhage. [PDF]

open access: yesJ Cardiovasc Magn Reson
Tyler A   +8 more
europepmc   +1 more source

The BPPV-SQ: Development and Clinical Evaluation of a Brief Screening Questionnaire for Benign Paroxysmal Positional Vertigo. [PDF]

open access: yesAudiol Res
Asprella-Libonati G   +10 more
europepmc   +1 more source

Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study). [PDF]

open access: yesAdv Ther
Roifman CM   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy